Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response

NCT02240888 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT02240888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02240888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response
Lead sponsor
Region Skane
Phase
Not applicable
Overall status
Completed
Start date
October 31, 2011
Completion date
May 31, 2018
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ra, scleroderma, sjögrens, sle, syndrome, vasculitis